Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer versus placebo in iron deficiency anaemia intolerant or unresponsive to oral iron
2014-001518-25Phase 3Terminated
- Sponsor
- Pharmacosmos
- Start
- Aug 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Iron isomaltoside 1000 with Placebo (2 arms). Primary endpoint: Proportion of subjects with haemoglobin increase of at least 2 g/dL from baseline at any time from week 1 to week 5. Started Aug 2014; status: terminated.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2014-001518-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001518-25.